Drug development against the hippo pathway in mesothelioma
Woodard GA, Yang YL, You L, Jablons DM. Drug development against the hippo pathway in mesothelioma. Translational Lung Cancer Research 2017, 6: 335-342. PMID: 28713678, PMCID: PMC5504108, DOI: 10.21037/tlcr.2017.06.02.Peer-Reviewed Original ResearchYAP/TEADCell pathwaysCell contact inhibitionStem cell populationCancer stem cell populationStem cell pathwaysTumor suppressor geneDownstream YAPHippo pathwaySuppressor geneContact inhibitionYAP inhibitorConventional cytotoxic drugsCell populationsMalignant pleural mesotheliomaPathwayDrug developmentTumor resistanceUltimate targetTEADGenesOncogeneYAPEffective chemotherapy drugsChemotherapy drugs
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply